article thumbnail

Legal Turmoil in the Pharmaceutical Industry: AbbVie, Purdue, and Beyond

Complex Discovery

Editor’s Note: In a legal confrontation that could significantly impact the pharmaceutical industry, AbbVie has petitioned the U.S. Adding to the legal drama, the pharmaceutical industry faces challenges in Mississippi, where U.S. has petitioned the U.S.

article thumbnail

Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial

Insurance Journal

is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant. Merck & Co. Lawyers for a Los Angeles woman will argue Monday that …

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Texas Pharmacy Owner Sentenced in $41M Health Insurance Fraud

Insurance Journal

A Dallas pharmacy owner who routinely billed insurance companies for headache sprays, pain creams, and scar creams never dispersed to patients was sentenced last week to 10 years in federal prison, announced U.S. Attorney for the Northern District of Texas …

Insurance 105
article thumbnail

Sedgwick: Product Recalls Dropped in Q2 in 5 Key Industries

Insurance Journal

decreased across the automotive, consumer product, food and drink, medical device and pharmaceutical industries in the second quarter, according to a new report from Sedgwick. Product recalls in the U.S. Sedgwick’s U.S. Recall Index found the 788 recalls across those …

article thumbnail

Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of $64.6 Million Penalty

Insurance Journal

Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%. The justices turned …

article thumbnail

Jazz Pharma to Pay $145 Million to Settle Narcolepsy Drug Antitrust Case

Insurance Journal

Jazz Pharmaceuticals JAZZ.O said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in the U.S., is used for the …

article thumbnail

Jury Awards Baltimore $266 Million in Damages After Opioid Trial

Insurance Journal

A jury has awarded the city of Baltimore $266 million in damages in its suit against pharmaceutical firms McKesson and AmerisourceBergen for their part in the city’s opioid epidemic. With the jury award, the city has notched another win for …